Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Epion Therapeutics logo — A clinical-stage company developing a minimally-invasive tre...

Epion Therapeutics

A clinical-stage company developing a minimally-invasive treatment for keratoconus

Founded 2012 United States Burlington, United States 12 employees Series A Total: $32.00M Biotechnology, Health Care +3

General Information

Company Name Epion Therapeutics
Founded Year 2012
Location United States Burlington, United States +1
Employees 12
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Series A
Social

Get notified when Epion Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Epion Therapeutics

Epion Therapeutics is a biotechnology startup based in the United States, founded in 2012. The company is focused on developing innovative treatments for corneal diseases, with the specific aim of addressing keratoconus, a common type of corneal ectasia. Epion's flagship product, EpiSmart, is a transformative cross-linking system designed to be minimally invasive, reducing discomfort and significantly cutting down recovery time compared to existing standards of care. Epion's approach is distinguished by its potential to treat both eyes simultaneously, eliminating the need for further deterioration. Notably, the company's last investment amounted to $32.00M, secured in a Series A round on September 30, 2022. The funding was provided by the Global Health Investment Fund (GHIF), underscoring investor confidence in Epion's vision-preserving solutions. With an elegant epi-on approach that avoids disrupting the epithelium, Epion is poised to enhance the standard of care, offering safer and more accessible treatments to millions of patients globally. By addressing a critical unmet need in eye care, Epion Therapeutics presents an attractive opportunity for venture capital investors seeking to support disruptive solutions in the pharmaceutical and healthcare industries.

Taxonomy: clinical-stage company, corneal diseases, keratoconus, minimally-invasive treatment, EpiSmart, cross-linking system, epithelium, vision care, medical innovation, early intervention, ophthalmology, corneal ectasia, Michael W. Belin, vision preservation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1 •••• •••• 30 Sep 2022

Epion Therapeutics Alternatives & Competitors

Epion Therapeutics vs
Trefoil Therapeutics
Trefoil Therapeutics United States

Developing first-in-class investigational medicines for serious corneal diseases and disorders

Series Unknown
11 employees
Biotechnology, Health Care
Epion Therapeutics vs
Visionary Eye Doctors
Visionary Eye Doctors United States

Advanced technology with a loving touch.

64 employees
Fashion, Health Care
Epion Therapeutics vs
AcuFocus
AcuFocus

Innovative solutions for presbyopia treatment, enabling clear vision with KAMRA inlays and precise s...

Series Unknown
Health Care, Medical Devices

FAQ About Epion Therapeutics

A clinical-stage company developing a minimally-invasive treatment for keratoconus
Epion Therapeutics was founded in 2012.
Epion Therapeutics is headquartered in Burlington, United States.
Epion Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences, Pharmaceutical.
Epion Therapeutics has approximately 12 employees.
Epion Therapeutics has completed 1 funding round, raising a total of $32.00M. The latest funding stage is Series A.
Top alternatives and competitors to Epion Therapeutics include Trefoil Therapeutics, Visionary Eye Doctors, AcuFocus, Tres Vision Group, CORNEA PROJECT S.L. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Epion Therapeutics and Trefoil Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Epion Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy